Evidence map›Paper›PMID 25618516›Full record

ArticleAmerican journal of hypertension2015

Variant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index.

Jin Li, Jinxiu Shi, Wei Huang, Jielin Sun, Ying Wu, Qing Duan, Jingchun Luo, Leslie A Lange, Penny Gordon-Larsen, S Lilly Zheng and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of hypertension, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Jin LiDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Curriculum in Bioinformatics & Computational Biology, University of North Carolina, Chapel Hill, North Carolina, USA;
Jinxiu ShiDepartment of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China;
Wei HuangDepartment of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China;
Jielin SunCenter for Cancer Genomics, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA;
Ying WuDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA;
Qing DuanDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Curriculum in Bioinformatics & Computational Biology, University of North Carolina, Chapel Hill, North Carolina, USA;
Jingchun LuoLineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA;
Leslie A LangeDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Curriculum in Bioinformatics & Computational Biology, University of North Carolina, Chapel Hill, North Carolina, USA;
Penny Gordon-LarsenCarolina Population Center, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA;
S Lilly ZhengCenter for Cancer Genomics, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA; Present address: Program for Personalized Cancer Care and Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA (J.X., S.L.Z.); Center for Genomic Translational Medicine and Prevention, Fudan School of Public Health, Fudan University, Shanghai, P.R. China (J.X.); Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, P.R. China (S.L.Z.).
Wentao YuanDepartment of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China;
Ying WangDepartment of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China;
Barry M PopkinCarolina Population Center, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA;
Zengnan MoInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China;
Jianfeng XuCenter for Cancer Genomics, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA; Present address: Program for Personalized Cancer Care and Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA (J.X., S.L.Z.); Center for Genomic Translational Medicine and Prevention, Fudan School of Public Health, Fudan University, Shanghai, P.R. China (J.X.); Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, P.R. China (S.L.Z.).
Shufa DuCarolina Population Center, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA;
Karen L MohlkeDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Curriculum in Bioinformatics & Computational Biology, University of North Carolina, Chapel Hill, North Carolina, USA;
Ethan M LangeDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Curriculum in Bioinformatics & Computational Biology, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA; elange@med.unc.edu.
University of North Carolina at Chapel Hill · USChinese National Human Genome Center · CNChinese National Human Genome Center at Shanghai · CNFudan University · CNFirst Affiliated Hospital of GuangXi Medical University · CNUNC Lineberger Comprehensive Cancer CenterWake Forest University · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
MONITORING SOCIAL CHANGE: HEALTH, REPRODUCTION, AGINGR01HD030880 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADAIR, LINDA S, POPKIN, BARRY M · 1994 to 2024
$27.0M
Carolina Population CenterR24HD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MORGAN, SAMUEL PHILIP · 2005 to 2014
$10.0M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Gene-Environment Interactions and Weight GainR01HD057194 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GORDON-LARSEN, PENNY, NORTH, KARI E. · 2008 to 2019
$5.9M
Emergence of Cardiometabolic Risk Across the Lifecycle in ChinaR01HL108427 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GORDON-LARSEN, PENNY · 2012 to 2015
$2.7M
CHILD HEALTH EFFECTS OF RAPID SOCIO-DEMOGRAPHIC CHANGER01HD038700 · NICHD · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI POPKIN, BARRY M · 2000 to 2004
$1.5M
Nutrition-Related NCD Prevention Training in ChinaD43TW009077 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI POPKIN, BARRY M · 2011 to 2015
$1.1M
The interplay between genes and environment on cardiovascular disease phenotypesR21HL126045 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LANGE, ETHAN MATHER, LANGE, LESLIE A · 2015 to 2016
$447k
Heterogeneity in Cardiometabolic Risk with Obesity: Who Is at Risk?R21DK089306 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GORDON-LARSEN, PENNY · 2010 to 2011
$405k
FIC NIH HHS D43 TW009077NHLBI NIH HHS R01 HL108427NHLBI NIH HHS R01HL108427NHLBI NIH HHS R21 HL126045NHLBI NIH HHS R21HL126045NICHD NIH HHS P2C HD050924NICHD NIH HHS R01 HD030880NICHD NIH HHS R01 HD038700NICHD NIH HHS R01 HD057194NICHD NIH HHS R01HD30880NICHD NIH HHS R01HD38700NICHD NIH HHS R24 HD050924NIDDK NIH HHS P30 DK056350NIDDK NIH HHS P30DK056350NIDDK NIH HHS R21 DK089306NIDDK NIH HHS R21DK089306NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

backgroundThe objective of this study was to investigate the genetic association of 4 candidate variants with blood pressure and test the modifying effects of environmental factors including age, sex, and body mass index (BMI).

methodsWe used a linear mixed-effects model to test for variant main effects and variant interactions with age, sex, and BMI on systolic (SBP) and diastolic (DBP) blood pressure in 7,319 Chinese adults from the China Health and Nutrition Survey (CHNS). We attempted to replicate our significant interaction findings in 1,996 Chinese men from the Fangchenggang Area Male Health and Examination Survey (FAMHES).

resultsTwo variants (rs11105378 near ATP2B1 and rs1458038 near FGF5) were significantly associated (P < 0.00625 = 0.05/8) with both SBP and DBP in CHNS. Variant rs1378942 near CSK was nominally associated with SBP (P = 0.01). The signal at rs1458038 exhibited a genotype-by-BMI interaction affecting blood pressure (P interaction = 0.0018 for SBP; P interaction = 0.049 for DBP), with the strongest variant effects in those with the highest BMI. In FAMHES, rs1458038 also showed stronger effects on SBP and DBP among men with the highest BMI.

conclusionsOur findings suggest high BMI increases the effect of the blood pressure-increasing allele at rs1458038 near FGF5, further highlighting the importance of obesity prevention in reducing hypertension risk.

Indexed as

AdultAgedAllelesAsian PeopleBlood PressureBody Mass IndexChinaCSK Tyrosine-Protein KinaseFemaleFibroblast Growth Factor 5GenotypeHumansHypertensionLinear ModelsLongitudinal StudiesMaleATP2B1 protein, humanCSK protein, humanCSK Tyrosine-Protein KinaseFGF5 protein, humanFibroblast Growth Factor 5Plasma Membrane Calcium-Transporting ATPasessrc-Family Kinasesblood pressureBMIFGF5hypertensioninteraction.

Identifiers

PMID25618516
PMCPMC4542636
OpenAlexW2166151504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.